Advair HFA 115/21mcg Oralinh 120s

Manufacturer GLAXO SMITH KLINE Active Ingredient Fluticasone and Salmeterol Inhaler(floo TIK a sone & sal ME te role) Pronunciation AD-vair H-F-A (floo TIK a sone & sal ME te role)
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Bronchodilator/Corticosteroid Combination
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA)
🀰
Pregnancy Category
Not available
βœ…
FDA Approved
Aug 2006
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Advair HFA is an inhaler that contains two medicines: fluticasone and salmeterol. Fluticasone is a steroid that helps reduce inflammation in your lungs, making it easier to breathe. Salmeterol is a long-acting bronchodilator that helps open up your airways for up to 12 hours. This medicine is used regularly, twice a day, to prevent asthma attacks and improve breathing. It is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Using Your Inhaler

Continue to use this medication as directed by your doctor or healthcare provider, even if you feel well.
Take your dose at the same time every day.
After each use, rinse your mouth with water, but do not swallow the rinse water. Instead, spit it out.
If you are using multiple inhaled medications, ask your doctor which one to use first.

Preparing and Using Your Inhaler

Shake the inhaler well before each use.
Before using the inhaler for the first time, prime it by spraying 4 test sprays into the air, away from your face.
If the inhaler has not been used for more than 4 weeks or if it has been dropped, prime it again by spraying 2 test sprays into the air, away from your face. Shake the inhaler well before each test spray.
After using your dose, replace the cap on the inhaler.

Important Safety Precautions

This medication is flammable, so do not use it near an open flame or while smoking.
Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, discard it when the counter reaches "0".

Storing and Disposing of Your Medication

Store the inhaler at room temperature in a dry place, away from the bathroom.
Store the inhaler with the mouthpiece facing down.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular dosing schedule.
Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Use your inhaler exactly as prescribed, twice a day, every day, even if you feel well.
  • Shake the inhaler well before each use.
  • Rinse your mouth with water and spit it out after each dose to help prevent a fungal infection (thrush) in your mouth and throat.
  • Do NOT use Advair HFA for sudden breathing problems; use your fast-acting rescue inhaler (e.g., albuterol) for those.
  • Keep track of how many puffs you have used and discard the inhaler after the labeled number of actuations or when the dose counter reads zero.
  • Do not exceed the prescribed dose.
  • Avoid triggers that worsen your asthma (e.g., smoke, allergens, cold air).
  • Maintain good hydration and a healthy lifestyle.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 2 inhalations twice daily, approximately 12 hours apart
Dose Range: 115 - 230 mg

Condition-Specific Dosing:

asthmaMaintenance: 2 inhalations (115/21 mcg) twice daily
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For children 4 to 11 years of age, Advair HFA 45/21 mcg or 115/21 mcg, 2 inhalations twice daily. For 115/21 mcg, typically for older children/adolescents.
Adolescent: 12 years and older: 2 inhalations (115/21 mcg) twice daily
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended
Moderate: No specific adjustment recommended
Severe: No specific adjustment recommended, but monitor for systemic effects if severe impairment is present.
Dialysis: No specific adjustment recommended

Hepatic Impairment:

Mild: No specific adjustment recommended
Moderate: No specific adjustment recommended
Severe: Use with caution; monitor for increased systemic corticosteroid effects due to potential for increased fluticasone exposure.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways by inhibiting multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in allergic and non-allergic-mediated inflammation. Salmeterol xinafoate is a selective, long-acting beta2-adrenergic agonist (LABA). It acts locally in the lung to stimulate beta2-receptors in bronchial smooth muscle, leading to bronchodilation by increasing cyclic AMP levels, which relaxes bronchial smooth muscle.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (<30% for oral inhalation due to high first-pass metabolism). Salmeterol: Low systemic bioavailability (<5% for oral inhalation).
Tmax: Fluticasone: 0.5-1 hour (systemic). Salmeterol: 5-10 minutes (systemic).
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: Fluticasone: 318 L. Salmeterol: Not extensively characterized, but widely distributed.
ProteinBinding: Fluticasone: ~91%. Salmeterol: ~96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: ~8 hours (terminal). Salmeterol: ~5.5 hours (terminal).
Clearance: Fluticasone: High systemic clearance (1150 mL/min). Salmeterol: High systemic clearance.
ExcretionRoute: Fluticasone: Primarily fecal (as metabolites). Salmeterol: Primarily fecal (as metabolites), minor renal.
Unchanged: Fluticasone: <5% in urine. Salmeterol: <1% in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (bronchodilation). Fluticasone: Days to weeks for full anti-inflammatory effect.
PeakEffect: Salmeterol: 2-4 hours. Fluticasone: Several days to 2 weeks.
DurationOfAction: Salmeterol: 12 hours. Fluticasone: Sustained anti-inflammatory effect with twice-daily dosing.
Confidence: Medium

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, placebo-controlled US study (SMART) showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of LABAs. The concomitant use of an inhaled corticosteroid (ICS) and a LABA has been shown to decrease the risk of asthma-related hospitalization and death. Therefore, Advair HFA should only be used in patients with asthma who are currently receiving but are inadequately controlled on an ICS or whose disease severity clearly warrants initiation of treatment with both an ICS and a LABA. Once asthma control is achieved and maintained, assess the patient at regular intervals and, if possible, step down therapy (e.g., to an ICS alone).
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Excessive thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ Abnormal heartbeat
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Fainting
+ Changes in vision
Chest pain or pressure
Rapid or irregular heartbeat
Shakiness
Nervousness or excitability
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Fatigue or weakness
Vaginal itching or discharge
Weight gain
Mouth irritation or sores
Redness or white patches in the mouth or throat

Respiratory Warning

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek immediate medical attention.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Headache
Upset stomach or vomiting
Throat irritation
* Common cold symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for your rescue inhaler (e.g., using it more than twice a week, not including exercise-induced asthma)
  • Signs of an allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Chest pain or fast/irregular heartbeat
  • Severe headache or dizziness
  • Muscle cramps or weakness
  • Vision changes (e.g., blurred vision, eye pain)
  • White patches in your mouth or throat (oral thrush)
  • Hoarseness or voice changes
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including the symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any medications you are taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, that may interact with this medication. Certain medications used to treat conditions like HIV, infections, and depression should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.

To ensure your safety, it is crucial to discuss all of your medications (prescription and OTC), natural products, vitamins, and health conditions with your doctor and pharmacist. This will help determine whether it is safe to take this medication in conjunction with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. The full effect of this drug may not be apparent until after 1 week of use.

If you have diabetes (high blood sugar), consult with your doctor, as this medication may increase your blood sugar levels. Monitor your breathing problems closely, and immediately contact your doctor if they worsen, if your rescue inhaler becomes less effective, or if you need to use it more frequently.

Do not exceed the prescribed dose or frequency of this medication, as overdoses of this type of drug have been fatal. Consult with your doctor if you have any concerns.

When transitioning from an oral steroid to another form of steroid, there is a risk of severe and potentially life-threatening side effects. Be aware of signs such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these symptoms.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in such situations.

Long-term use of this medication may increase the risk of developing cataracts or glaucoma. Consult with your doctor and undergo regular eye exams as recommended.

Prolonged use of this medication may also lead to osteoporosis (weak bones). Discuss your risk factors with your doctor and undergo bone density tests as advised.

You may be more susceptible to infections while taking this medication. Practice good hygiene by washing your hands frequently, and avoid close contact with people who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these diseases, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary, so consult with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, discuss the benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia, arrhythmias, tremor, headache, palpitations, nausea, dizziness, hypokalemia, hyperglycemia, metabolic acidosis.
  • Fluticasone overdose: Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (e.g., Cushing's syndrome, adrenal suppression).

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function and serum potassium levels.

Drug Interactions

πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, cobicistat): Can significantly increase systemic exposure of fluticasone and salmeterol, leading to increased risk of systemic corticosteroid effects (e.g., Cushing's syndrome, adrenal suppression) and cardiovascular effects (e.g., QT prolongation, arrhythmias) from salmeterol. Concomitant use is not recommended.
  • Non-selective beta-blockers (e.g., propranolol): Can antagonize the bronchodilatory effect of salmeterol and may produce severe bronchospasm in patients with asthma. Avoid concomitant use.
🟑

Moderate Interactions

  • Other sympathomimetics: May potentiate adverse cardiovascular effects of salmeterol.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): Can potentiate the cardiovascular effects of salmeterol. Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
  • Diuretics (e.g., loop or thiazide diuretics): May potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses of salmeterol.
  • Other QTc-prolonging drugs: Increased risk of ventricular arrhythmias with salmeterol.
🟒

Minor Interactions

  • Not specifically identified as minor, but general caution with drugs affecting electrolyte balance or cardiac rhythm.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy

Asthma Control Assessment (e.g., ACT score)

Rationale: To quantify baseline symptom burden and guide treatment goals.

Timing: Prior to initiation of therapy

Adrenal Function (if transitioning from systemic corticosteroids)

Rationale: To assess for adrenal suppression.

Timing: Prior to or during transition

πŸ“Š

Routine Monitoring

Asthma Symptom Control

Frequency: Regularly (e.g., every 1-3 months initially, then every 3-12 months)

Target: Minimal symptoms, infrequent rescue inhaler use, no nocturnal awakenings

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings, decreased peak flow

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Improvement towards personal best or predicted values

Action Threshold: Deterioration or lack of improvement

Adverse Effects (e.g., oral candidiasis, hoarseness, tremor, palpitations)

Frequency: At each follow-up visit

Target: Absence or minimal

Action Threshold: Presence of significant or bothersome side effects

Growth in Pediatric Patients

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity

Action Threshold: Growth deceleration

Bone Mineral Density (for long-term, high-dose ICS use)

Frequency: Periodically, as clinically indicated (e.g., DEXA scan)

Target: Maintain bone density

Action Threshold: Evidence of bone loss

Ocular Examination (for long-term ICS use)

Frequency: Periodically, as clinically indicated (e.g., annually)

Target: Absence of cataracts or glaucoma

Action Threshold: Development of cataracts or glaucoma

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased frequency of rescue inhaler use (e.g., more than 2 days a week, not including exercise-induced bronchospasm)
  • Nocturnal asthma symptoms or awakenings
  • Signs of oral candidiasis (white patches in mouth/throat)
  • Hoarseness or dysphonia
  • Tremor or nervousness
  • Palpitations or rapid heart rate
  • Muscle cramps

Special Patient Groups

🀰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies of Advair HFA in pregnant women. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol. Monitor infants born to mothers receiving corticosteroids during pregnancy for signs of hypoadrenalism.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity observed in animal studies with high doses of individual components.
Second Trimester: Risk of fetal growth restriction or adrenal suppression with prolonged high-dose corticosteroid exposure.
Third Trimester: Risk of fetal adrenal suppression, requiring monitoring of the neonate.
🀱

Lactation

Low levels of fluticasone and salmeterol are expected to be present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Advair HFA and any potential adverse effects on the breastfed infant from Advair HFA or from the underlying maternal condition. Caution is advised.

Infant Risk: Low risk of adverse effects on the breastfed infant due to low systemic exposure and high protein binding, but monitor for signs of systemic corticosteroid effects or beta-agonist effects (e.g., irritability, poor feeding).
πŸ‘Ά

Pediatric Use

Safety and effectiveness established for asthma in patients 4 years of age and older. Monitor growth velocity in pediatric patients receiving ICS, as long-term use may affect growth. Use the lowest effective dose. Proper inhaler technique is crucial.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, caution should be exercised in elderly patients due to the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy. Monitor for cardiovascular effects and bone mineral density.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Advair HFA is a maintenance medication and should be used consistently, twice daily, for optimal asthma control. It is NOT a rescue inhaler for acute symptoms.
  • Proper inhaler technique is critical for drug delivery. Patients should be instructed and regularly re-evaluated on their technique. Using a spacer (valved holding chamber) is recommended, especially for children and those with difficulty coordinating actuation and inhalation.
  • Always rinse mouth with water and spit after each dose to minimize the risk of oral candidiasis (thrush) and dysphonia.
  • Patients should be provided with a fast-acting beta2-agonist (e.g., albuterol) for acute asthma symptoms.
  • The dose counter on the inhaler indicates the number of remaining actuations. Discard the inhaler when the counter reads zero or after the expiration date.
  • If asthma symptoms worsen or the need for rescue inhaler increases, patients should contact their healthcare provider immediately, as this may indicate worsening asthma control requiring re-evaluation of therapy.
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., Flovent HFA/Diskus, Pulmicort Flexhaler, Qvar RediHaler)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations or refractory asthma)
  • Immunomodulators (e.g., omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab - for severe asthma)
πŸ’°

Cost & Coverage

Average Cost: $300 - $400+ per 120 actuations inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Brand name), Tier 1 (Generic DPI)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.